The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Volkov V.P.

Tverskoĭ tsentr sudebnykh kspertiz

Authors:

Volkov V.P.

More about the authors

Read: 4365 times

To cite this article:

Volkov VP. . S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11):75‑78. (In Russ.)

References:

  1. Boikikev Sv. Lekarstvennye porazheniya nosa, gorla i ushei. V kn.: Lekarstvennaya bolezn'. Pod red. G. Mazhdrakova i P. Popkhristova. Sofiya 1973; 481-506.
  2. Vilenskii B.S. Zlokachestvennyi neirolepticheskii sindrom. Nevrol zhurn 2003; 8: 4: 4-6.
  3. Volkov V.P. Kozhnye oslozhneniya fenotiazinovoi terapii (obzor literatury). Psikhiat i psikhofarmakoter 2010; 12: 3: 33-37.
  4. Volkov V.P. Zlokachestvennyi neirolepticheskii sindrom (obzor sovremennoi inostrannoi literatury). Psikhiat i psikhofarmakoter 2010; 12: 6: 28-35.
  5. Malin D.I., Kozyrev V.N., Neduva A.A., Ravilov R.S. Zlokachestvennyi neirolepticheskii sindrom: kriterii diagnostiki i printsipy terapii. Sots i klinich psikhiat 1997; 7: 1: 76-80.
  6. Popkhristov P., Bazhdekov B. Porazhenie kozhi lekarstvami. V kn.: Lekarstvennaya bolezn'. Pod red. G. Mazhdrakova i P. Popkhristova. Sofiya 1973; 79-163.
  7. Tsygankov B.D. Kliniko-patogeneticheskie zakonomernosti razvitiya febril'nykh pristupov shizofrenii i sistema ikh terapii. M 1997; 232.
  8. Ananth J., Parameswaran S., Gunatilake S. et al. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 2004; 65: 464-70.
  9. Ayd F.J. Reintroducing antipsychotics in NMS patients. Int Drug Ther Newsletter 1999; 34: 29-30.
  10. Benzer T. Neuroleptic Malignant Syndrome. Medicine 2010; medscape.com/816018-overview.
  11. Bhanushali M.J., Tuite P.J. The evaluation and management of patients with neuroleptic malignant syndrome. Neurol Clin 2004; 22: 2: 389-411.
  12. Bottoni T.N. Neuroleptic Malignant Syndrome: A Brief Review. Hospital Physician March 2002; 58-63: www.turner-white.com
  13. Cane M. Poisoned Love 2009; www.poisonedlove.com/antipsychotic-poisoning.php
  14. Caroff S.N. Neuroleptic malignant syndrome. In: Neuroleptic Malignant Syndrome and Related Conditions, 2nd ed. Eds. S.C. Mann et al. Washington DC: American Psychiatric Publishing 2003; 1-44.
  15. Chandran G.J., Mikler J.R., Keegan D.l. Neuroleptic malignant syndrome: case report and discussion. CMAJ 2003; 169: 5: 439-442.
  16. Draper R. Neuroleptic malignant syndrome 2009; www.patient.co.uk/showdoc/
  17. Gupta S., Nihalani N.D. Neuroleptic Malignant Syndrome: A Primary Care Perspective. J Clin Psychiatry 2004; 6: 5: 191-194.
  18. Hall R.C.W., Hall R.C.W., Chapman M. Neuroleptic Malignant Syndrome in the Elderly. Diagnostic Criteria, Incidence, Risk Factors, Pathophysiology, and Treatment. Clin Geriatrics 2006; 14: 5: 39-46.
  19. Hammergren D.J. Neuroleptic malignant syndrome: an online resource for healthcare providers. USA: University of Arizona 2006; 61.
  20. Khan H.M., Syed N.A., Sheerani M. et al. Neuroleptic malignant syndrome: need for early diagnosis and therapy. J Ayub Med Coll Abbottabad 2006; 18: 1: 17-21.
  21. Mann S.C., Caroff S.N., Keck P.E., Lazarus A. Neuroleptic Malignant Syndrome and Related Conditions. 2th ed. Washington, DC: American Psychiatric Publishing 2003.
  22. Murak E. Neuroleptic malignant syndrome. Psychiat Pol 1995; 29: 3: 349-358.
  23. Pelonero A.L., Levenson J.L., Pandurangi A.K. Neuroleptic Malignant Syndrome: A Review. Psychiatr Serv 1998; 49: 9: 1163-1172.
  24. Picard L.S., Lindsay S., Strawn J.R. et al. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy 2008; 28: 4: 530-535.
  25. Rodriguez O.P., Dowell M.S. Acasereport of neuroleptic malignant syndrome without fever in a patient given aripiprazole. J Okla State Med Assoc 2006; 99: 7: 435-438.
  26. Strawn J.R., Keck P.E.Jr. Early bicarbonate loading and dantrolene for ziprasidone/haloperidol-induced neuroleptic malignant syndrome (letter). J Clin Psychiatry 2006; 67: 677.
  27. Tonkonogy J., Sholevar D.P. Neuroleptic Malignant Syndrome. eMedicine 2010; medscape.com/article/288482-overview
  28. Vesperini S., Papetti F., Pringuey D. Are catatonia and neuroleptic malignant syndrome related conditions? Encephale 2010; 36: 2: 105-110.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.